Prot #GB43311: A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease

Project: Research project

Project Details

StatusActive
Effective start/end date5/3/22 → 5/3/26

Funding

  • PPD Investigator Services, LLC ((OE) Prot #GB43311 // (OE) Prot #GB43311)
  • Genentech, Inc ((OE) Prot #GB43311 // (OE) Prot #GB43311)